Swiss TPH and dHealth have collaborated on two use cases related to infectious diseases. The first use case developed was the utilization of dHealth’s blockchain to track the transport of rabies medication, as well as the recipient’s health status after inoculation. The second was related to COVID-19, and it was focused on tracking COVID-19 outbreaks.
The partnership between dHealth and the Swiss Tropical and Public Health Institute (Swiss TPH) serves as an exemplary model of how technology and public health expertise can come together to tackle global healthcare challenges. This collaborative synergy has resulted in two initiatives that have not only addressed immediate health issues but also laid the groundwork for more adaptive, data-driven healthcare systems for the future. These two initiatives are a project called Blockrabies, and the development of a COVID-19 module aimed to contain COVID-19 outbreaks.
There will certainly be more fruitful initiatives in the future.
The aforementioned blockrabies project is aimed at achieving zero human rabies deaths in Africa. This initiative employs a robust tracking system to monitor the distribution and administration of rabies post-exposure prophylaxis medication.
Utilizing dHealth's blockchain technology, the supply chain data was stored in a secure, transparent, and easily accessible manner. This allowed all project partners, including Swiss TPH, to monitor real-time developments, potentially averting fatalities and severe health conditions related to rabies. As a seal of its effectiveness and long-term vision, this supply chain solution is slated for institutionalization in Western Africa by 2024.
In the realm of pandemic response, the Private-Public Partnership consisting of dHealth, Swiss TPH, Novartis, and the University of Basel collaboratively developed a COVID-19 tracking module.
This tool allowed for real-time symptom reporting and diagnoses, thereby enabling swift contact tracing and self-isolation procedures. Although initially focused on COVID-19, the module's flexible architecture means it can be adapted for the surveillance of other diseases, showcasing the foresight built into these collaborative efforts.
The collaborative alliance between dHealth and Swiss TPH demonstrates the transformative power unleashed when technological innovation meets deep-rooted expertise in international public health. The outcomes not only address today's pressing health issues but also pave the way for a more resilient and adaptive global healthcare landscape.